UTHR
NASDAQ
$529.34
United Therapeutics Corp (UTHR)
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Sector:
Healthcare
Buy
Target: $663.46 (+25.34%)
Market Cap
$22B
EPS 5Y CAGR
+26.56%
Profit Margin
35.2%
P/E Ratio
17.96
Price Chart
Valuation
Market Cap$22B
P/E17.96
Forward P/E19.49
PEG1.91
P/S7.08
P/B3.83
Profitability
Total Revenue (TTM)$3.17B
Gross Profit (TTM)$2.74B
EBITDA$1.52B
Profit Margin35.2%
Operating Margin41.7%
EPS$29.61
Financial Health
Free Cash Flow Yield4.54%
Growth & Risk
EPS 5Y CAGR+26.56%
Revenue 5Y CAGR+16.05%
FCF 5Y CAGR+12.12%
Beta (5Y)0.41
Sharpe Ratio1.35